Susquehanna International Group’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Susquehanna International Group’s Portfolio SVNT Stock Details SVNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-121,900	Closed	-$76K	–	9761
2013 Q3	$76K	Buy	121,900 +21,300	+21%	+$13.6K	﹤0.01%	8164
2013 Q2	$56K	Buy	+100,600	New	+$70.1K	﹤0.01%	7956

Other funds holding SVNT

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return

PSC

Prentiss Smith & Co Brattleboro, Vermont $182M AUM 26.44% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Susquehanna International Group's SVNT Position: Q4 2013 in Review

Susquehanna International Group sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 120,673 shares — an estimated $75K sold.

Susquehanna International Group first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $75K in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

Susquehanna International Group reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
Susquehanna International Group sold 120,673 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $75K.
Susquehanna International Group first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
Susquehanna International Group's SAVIENT PHARMACEUTICALS INC position peaked at $75K in Q3 2013.
7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Susquehanna International Group's 13F filing for Q4 2013, filed 13 Feb 2014.